Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer

Everolimus inhibits mTOR kinase activity and its downstream targets by acting on mTORC1 and has anti-tumorigenic activity in ovarian cancer. Clinical and epidemiologic data find that obesity is associated with worse outcomes in ovarian cancer. In addition, obesity leads to hyperactivation of the mTO...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Hui, Zhong, Yan, Jackson, Amanda L., Clark, Leslie H., Kilgore, Josh, Zhang, Lu, Han, Jianjun, Sheng, Xiugui, Gilliam, Timothy P., Gehrig, Paola A., Zhou, Chunxiao, Bae, Victoria L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991459/
https://www.ncbi.nlm.nih.gov/pubmed/26959121
http://dx.doi.org/10.18632/oncotarget.7934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991459/
https://www.ncbi.nlm.nih.gov/pubmed/26959121
http://dx.doi.org/10.18632/oncotarget.7934

Ejemplares similares